Galapagos NVEquity-NMS: GLPG
Equity-NMS: GLPG
$29.49
-0.31
(16 Apr)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$29.49
Open
$29.49
Today’s high
$29.58
Today’s low
$29.45
52W low
$29.45
52W high
$45.21
1Y
-22.98%
5Y
-24.03%
Shares O/S
65.90M
Market cap
1.94B
Insights
GLPG has made a new 52 Wk low. 52 Wk low stocks tend to underperform in the near term.
GLPG price is below its 200 day moving average
GLPG PE is in the top end of its range over the past 2 years
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About Galapagos NV

Galapagos NV is a Belgium-based clinical-stage biotechnology company. The Company is engaged in the discovery and development of small molecule medicines with novel modes of action. Its pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery small-molecule and antibody programs in cystic fibrosis, inflammation, and other indications.

The Company focuses on developing a portfolio of clinical-stage therapies for the enhancement of existing treatment paradigms. It develops transformational medicines in areas of high unmet need by combining internal with external science with the goal to add years of life and improve quality of life of patients across the globe. Galapagos NV also discovers which proteins that are involved in causing diseases such as, rheumatoid, arthritis, inflammatory bowel disease and fibrosis. The Company acquired CellPoint and AboundBio in order to develop a cell therapy, which is a potential transformative treatment of different types of cancer. .


FAQs

Can I buy Galapagos NV shares in India?
How to buy Galapagos NV shares in India?
What is the share price of Galapagos NV?
What is the Market Capitalization of Galapagos NV?
What is the PE ratio of Galapagos NV?
Is Galapagos NV a good stock to buy?
In which sector / industry does Galapagos NV operate?